Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...

A newly published study reports that APC-deficient cancer cells may depend on a single metabolic enzyme for survival, revealing a potential strategy for selectively targeting tumours associated with ...

Based on positive phase 3 trial results, a New Drug Application will be submitted to the Food and Drug Administration for daraxonrasib.

Cancer survival rates in the U.S. are the highest they’ve been since the 1970s. In 1970, only half of patients lived past five years. Now, at least 70 percent of U.S. cancer patients are surviving for ...

In a phase 3 trial for pancreatic ductal adenocarcinoma (PDAC), daraxonrasib significantly improved survival to 13.2 months, ...

Add Yahoo as a preferred source to see more of our stories on Google. More Americans diagnosed with cancer are now surviving the disease - marking a positive trend that experts say reflects the ...

The success of the Phase 3 study reverberated beyond the clinic, sending the company’s shares up more than a third in a single day.

A prospective study links sufficient vitamin D levels at the time of breast cancer diagnosis to improved overall survival.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. More people with cancer than ever are surviving at least ...

Rutgers researchers use a noninvasive MRI technique to detect differences in cellular energy recovery across age groups and ...

More Americans diagnosed with cancer are now surviving the disease - marking a positive trend that experts say reflects the effectiveness of early prevention and detection strategies, and advancements ...

More Americans diagnosed with cancer are now surviving the disease — marking a positive trend that experts say reflects the effectiveness of early prevention and detection strategies, and advancements ...